Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken-Ichi Fujimoto

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Neurology|October 11, 2002
Recombinant adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to realityShin-Ichi Muramatsu, Lijun Wang, Kunihiko Ikeguchi, et al.
Rinsho Shinkeigaku = Clinical Neurology|March 29, 2003
[A case of Crow-Fukase syndrome with respiratory failure due to bilateral diaphragmatic paralysis]Michito Namekawa, Shin-ichi Muramatsu, Ritsuo Hashimoto, et al.
Human Gene Therapy. Clinical Development|March 11, 2017
Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's DiseaseYoshihide Sehara, Ken-Ichi Fujimoto, Kunihiko Ikeguchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 8, 2010
A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's diseaseShin-ichi Muramatsu, Ken-ichi Fujimoto, Seiya Kato, et al.
Neuroscience Research|January 1, 2003
Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transportYan-Yan Lu, Li-Jun Wang, Shin-ichi Muramatsu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 15, 2002
Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosisLi-Jun Wang, Yan-Yan Lu, Shin-ichi Muramatsu, et al.
Movement Disorders Clinical Practice|April 6, 2019
Postural Abnormality in Parkinson's Disease: A Large Comparative Study With General PopulationYoshihito Ando, Ken-Ichi Fujimoto, Ken Ikeda, et al.
Human Gene Therapy|February 28, 2002
Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymesShin-Ichi Muramatsu, Ken-Ichi Fujimoto, Kunihiko Ikeguchi, et al.
Neurobiology of Aging|June 30, 2014
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's diseaseTaku Hatano, Manabu Funayama, Shin-Ichiro Kubo, et al.
Journal of Neurology|June 28, 2018
GCH1 mutations in dopa-responsive dystonia and Parkinson's diseaseHiroyo Yoshino, Kenya Nishioka, Yuanzhe Li, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Neurology|October 11, 2002
Recombinant adeno-associated viral vectors bring gene therapy for Parkinson's disease closer to realityShin-Ichi Muramatsu, Lijun Wang, Kunihiko Ikeguchi, et al.
Rinsho Shinkeigaku = Clinical Neurology|March 29, 2003
[A case of Crow-Fukase syndrome with respiratory failure due to bilateral diaphragmatic paralysis]Michito Namekawa, Shin-ichi Muramatsu, Ritsuo Hashimoto, et al.
Human Gene Therapy. Clinical Development|March 11, 2017
Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson's DiseaseYoshihide Sehara, Ken-Ichi Fujimoto, Kunihiko Ikeguchi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 8, 2010
A phase I study of aromatic L-amino acid decarboxylase gene therapy for Parkinson's diseaseShin-ichi Muramatsu, Ken-ichi Fujimoto, Seiya Kato, et al.
Neuroscience Research|January 1, 2003
Intramuscular injection of AAV-GDNF results in sustained expression of transgenic GDNF, and its delivery to spinal motoneurons by retrograde transportYan-Yan Lu, Li-Jun Wang, Shin-ichi Muramatsu, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 15, 2002
Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosisLi-Jun Wang, Yan-Yan Lu, Shin-ichi Muramatsu, et al.
Movement Disorders Clinical Practice|April 6, 2019
Postural Abnormality in Parkinson's Disease: A Large Comparative Study With General PopulationYoshihito Ando, Ken-Ichi Fujimoto, Ken Ikeda, et al.
Human Gene Therapy|February 28, 2002
Behavioral recovery in a primate model of Parkinson's disease by triple transduction of striatal cells with adeno-associated viral vectors expressing dopamine-synthesizing enzymesShin-Ichi Muramatsu, Ken-Ichi Fujimoto, Kunihiko Ikeguchi, et al.
Neurobiology of Aging|June 30, 2014
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's diseaseTaku Hatano, Manabu Funayama, Shin-Ichiro Kubo, et al.
Journal of Neurology|June 28, 2018
GCH1 mutations in dopa-responsive dystonia and Parkinson's diseaseHiroyo Yoshino, Kenya Nishioka, Yuanzhe Li, et al.
Pageof 2